Isao Goto
Municipal Hirakata City Hospital · 41 works · 889 citations · h-index 12
Top works
- Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)
- Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L
- Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer.
- [Gastrointestinal metastasis from lung cancer].
- Pulmonary tumor thrombotic microangiopathy caused by gastric cancer
- Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents
- Phase II Trial of Amrubicin for Second-Line Treatment of Advanced Non-small Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG0401)
- [Serotonin syndrome in a patient with small cell lung cancer].
- Phase II Study of Sequential Triplet Chemotherapy, Irinotecan and Cisplatin Followed by Amrubicin, in Patients with Extensive-Stage Small Cell Lung Cancer: West Japan Thoracic Oncology Group Study 0301
- First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumours
- Cytokeratin - positive rib osteosarcoma metastasizing to the small intestine
- Exacerbation of autoimmune myocarditis by an immune checkpoint inhibitor is dependent on its time of administration in mice
- Leptomeningeal Carcinomatosis in Patients with Lung Cancer.
- Gene amplification of ribosomal protein S6 kinase-1 and -2 in gastric cancer.
- Randomized phase III study comparing gefitinib (G) with erlotinib (E) in patients (pts) with previously treated advanced lung adenocarcinoma (LA): WJOG 5108L.
- Large Cell Neuroendocrine Carcinoma of the Lung withCancer-Associated Retinopathy
- Comparison Between Second- and Third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as First-line Treatment in Patients With Non-small-cell Lung Cancer: A Retrospective Analysis
- Selective effect of O-alkyl lysophospholipids on the growth of a human lung giant cell carcinoma cell line.
- A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site
- Temporal Changes in Echocardiographic Findings in Cardiac and Non-Cardiac Sarcoidosis Patients